Haemostasis Flashcards

1
Q

Define haemostasis

A

A precisely orchestrated series of regulatory processes that culminate in the formation of a blood clot that limits bleeding from an injured vessel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the purpose of haemostasis?

A

1) Allows blood to be in a fluid state in normal vessels
2) Formation of a localised haemostatic clot at sites of vascular injury
3) Prevents haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 3 components of haemostasis?

A

1) Vessel wall
2) Platelets
3) Coagulation cascade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the layers in a blood vessel?

A

1) Tunica intima
- Endothelium
- Basement membrane
- Connective tissue
- Internal elastic lamina

2) Tunica media
Circumferentially arranged smooth muscle

3) Tunica adventitia
Connective tissue containing vascular and neural supply

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the role of endothelium?

A

Normally endothelium cells are: Antiplatelet, anticoagulant, fibrinolytic.

Acts as a barrier between thrombogenic sub endothelium and coagulation factors in the blood.

Expresses factors which prevent thrombosis in undamaged vessels and limit clot formation to the site of vascular injury.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the role of platelets?

A

1) Form the initial haemostatic plug

2) Provide a surface for recruitment and concentration of coagulation factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 4 steps in haemostasis?

A

1) Vasoconstriction
2) Primary haemostasis
3) Secondary haemostasis
4) Clot stabilisation and resorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe what happens in vasoconstriction

A
  • Mediated by reflex neurogenic mechanisms and release of endothelin from endothelial cells
  • Minimise blood loss
  • Maximises interactions between platelets, clotting factors and vessel wall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 3 stages to the formation of the primary haemostatic plug?

A

1) Platelet adhesion
2) Platelet activation
3) Platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe what happens in platelet adhesion

A

1) Damage to vessel wall -> exposure of subendothelial matrix
2) von Willebrand Factor (vWF) binds to exposed subendothelial collagen
3) Platelets bind to collagen-bound vWF
4) Platelet adhesion – platelets bind directly to subendothelial collagen
5) Platelets change shape to promote platelet-platelet interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe what happens in platelet activation

A

1) Platelets change shape to promote platelet-platelet interactions
2) Conformational change in GPIIb/IIIa receptors
3) Platelet release reaction
4) Platelets also release thromboxane A2 (TXA2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is released in the Platelet Release Reaction?

A

Part of platelet activation in primary haemostasis
Secretory granules release:
- vWF
- fibrinogen
- Calcium (important for forming complexes in secondary haemostasis)
- Serotonin
- ADP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What happens in platelet aggregation?

A
  • ADP and TXA2 promote further platelet aggregation
  • Platelet-platelet interact via GPIIb/IIIa receptors and fibrinogen
  • Forms primary platelet plug. Not very stable so to stabilise, need secondary haemostasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What stage of haemostasis is fibrin generation?

A

Secondary haemostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe what happens in fibrin generation

A

1) Damage to vessel wall -> exposure of tissue factor (TF) on subendothelial cells
2) Tissue factor binds and activates factor VII -> coagulation (clotting) cascade!!
3) Thrombin generated -> cleaves fibrinogen into fibrin
4) Fibrin polymerises to form network around plug
5) Forms secondary haemostatic plug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the goal of the coagulation/clotting cascade?

A

To produce thrombin which converts fibrinogen to fibrin, stabilising the clot (secondary haemostasis)

17
Q

What are the 2 coagulation pathways?

A

Extrinsic pathway and intrinsic pathway. Both lead to a final common pathway.

18
Q

Describe the extrinsic pathway

A
  • Measured clinically as prothrombin time (PT)
  • Initiated by tissue factor
  • Tissue factor is not normally exposed to the blood, it is in the subendothelium – hence extrinsic

1) Exposed tissue factor (TF) converts Factor VII to FVIIa.
2) A complex is then formed containing FVIIa, TF, Ca+

19
Q

Describe the intrinsic pathway

A
  • Measured clinically as activated partial thromboplastin time (APTT)
  • Initiated when FXII comes into contact with a negatively charged surface (eg. An activated platelet) -> FXIIa

FXIIa -> FXIa -> FIXa -> FIXa + FVIIIa + Ca2+ (tenase complex)

The complex from the extrinsic pathway also helps activate FIX

20
Q

What are the three components of the tenase complex?

A

FVIIIa, FIXa and Ca2+

21
Q

What happens in the common pathway?

A

1) The complex from the extrinsic pathway and the tenase complex activate FX -> FXa.
2) FXa, FVa and Ca2+ form a prothrombinase complex.
3) The prothrombinase complex converts prothrombin (FII) to thrombin (FIIa)
4) Thrombin converts fibrinogen to fibrin
5) Thrombin also activates FXIII to FXIIIa which then converts fibrin into cross-linked fibrin (which is more stable).

22
Q

What are the three components of the prothrombinase complex?

A

FXa, FVa and Ca2+

23
Q

What are the actions of thrombin?

A

1) Conversion of fibrinogen to fibrin
2) Amplifies coagulation process by further activating:
FXI
FV
FVIII
3) Activates FXIII -> covalent cross-linking between fibrin polymers-> stabilises the secondary haemostatic plug.
4) Further platelet activation
Proinflammatory effects – contributes to tissue repair and angiogenesis
5) Anticoagulant effects – when interacting with normal endothelium -> helps limit clots to site of injury

24
Q

What are the factors which limit coagulation?

A

1) Dilution
2) Need for a negatively charged surface provided by activated platelets
3) Anticoagulation factors expressed by adjacent intact endothelium
4) Circulating inhibitors, e.g. antithrombin III – actively augmented by heparin-like molecules on intact endothelium -> inhibits thrombin, FIXa, FXa, FXIa, and FXIIa
5) Fibrinolytic cascade

25
Q

What does heparin do?

A
  • Binds reversibly to antithrombin III and enhances its inactivation of thrombin and FXa
  • Inhibits thrombosis (low dose) and prevents progression of existing clots (higher dose)
  • Used in prophylaxis and treatment of venous thromboembolism (VTE)
26
Q

What does unfractionated heparin do?

A

inactivates both FXa and thrombin

27
Q

What does Low Molecular Weight Heparin do?

A

Eg. Dalteparin

Primarily inactivates FXa

28
Q

What is the mechanism by which heparin works?

A

All forms of heparin bind and activate Antithrombin III by inducing a conformational change that “opens up” the Antithrombin III active site so it can bind to and inactivate FXa.

Unfractionated heparin also contains longer chains that can also stabilise Antithrombin III complexes with Thrombin, leading to Thrombin inactivation as well.

29
Q

What does Warfarin do?

A
  • Affects metabolism of vitamin K
  • Inhibits synthesis of vitamin K-dependent coagulation factors (factors VII, IX, X, and prothrombin)
  • Prophylaxis and treatment of venous thromboembolism and prevention of ischaemic stroke in atrial fibrillation
30
Q

What do New Oral Anticoagulants (NOACs) do?

A

Eg. dabigatran - a competitive, reversible inhibitor of thrombin

31
Q

Describe the process of clot stabilisation and resorption

A
  • FXIIIa mediates formation of covalent cross-links between fibrin polymers -> further stabilises clot
  • Fibrin and platelet aggregates undergo contraction to form a permanent plug
  • Counter-regulatory mechanisms limit the clotting to site of injury
  • Clot reabsorption and tissue repair
  • Involves the fibrinolytic system
32
Q

What is the fibrinolytic system?

A
  • Inactive circulating plasminogen is converted to plasmin
  • Plasminogen activator including tissue plasminogen activator (tPA)
  • Plasmin breaks down fibrin polymers
  • Antifibrinolytic factors oppose fibrinolysis
33
Q

What are D-dimers and what can they be used for?

A

D-dimers are fibrin degradation products.

Can be used as a clinical test. High D-dimer level can be indicative of disease. But not very specific.

34
Q

What are the differences between haemostasis and thrombosis?

A

Haemostasis allows:

  • Physiological process
  • Formation of a localised haemostatic clot at sites of vascular injury
  • In order to limit bleeding and prevent haemorrhage

Thrombosis

  • Pathological process
  • The formation of a solid mass of blood products in a vessel lumen (thrombus)
  • Can lead to vascular occlusion, ischaemia and infarction
35
Q

Define haemorrhage

A

Extravasation (leakage) of blood into the extravascular space.

Such as tissues, body cavities or out of the body.

36
Q

What are the causes of haemorrhage?

A

Damage to blood vessel, e.g. due to:

  • Trauma
  • Atherosclerosis
  • Inflammatory or neoplastic erosion
  • Chronically congested tissues

Defective haemostasis – haemorrhagic diatheses

37
Q

What are the factors affecting clinical significance of haemorrhage?

A

1) Volume of blood lost
2) Rate blood is lost
3) Medical fitness pre blood loss
4) Site of bleeding
5) Chronic or recurrent blood loss